Allevate Health offers FDA-approved, insurance-covered SPRAVATO® for adults facing treatment-resistant depression and acute suicidal thoughts. This fast-acting nasal spray is administered under expert supervision in a calm, supportive setting—helping you find relief when other treatments haven’t worked.

IV ketamine therapy at Allevate delivers fast and effective relief directly through the bloodstream. Each treatment is carefully tailored and monitored for maximum benefit. This method is a key part of our approach, offering new hope for those battling severe mental health conditions and chronic pain.

Medication management at Allevate ensures optimal treatment success through careful selection and monitoring of pharmaceutical interventions. Each prescription is precisely tailored to the individual's needs and continually adjusted for maximum benefit.

Ketamine has shown effectiveness in 70% of individuals with treatment-resistant depression, providing significant symptom reduction after treatment.

Ketamine’s rapid action on mood could potentially extend to providing quick relief from the symptoms of anxiety disorders.

Ketamine treatment has resulted in a long-lasting improvement in PTSD symptoms in majority of patients.

Ketamine’s action on neurotransmitters may offer an immediate reduction of OCD symptoms, providing a new option for those struggling.

For chronic pain, ketamine infusions have been used when other pain management strategies fail due to their effects on the central nervous system.

In cases of bipolar depression, ketamine can provide a swift improvement in symptoms for individuals with treatment-resistant bipolar disorder.

Ketamine offers quick symptom relief, often within hours, which can be crucial for treatment resistant conditions.

Ketamine is an alternative treatment when standard medications fail, covering a wider range of resistant cases.

Up to 70% of patients with treatment resistant depression see a significant reduction in symptoms with Ketamine.

Ketamine actively promotes the formation of new neural pathways, aiding brain repair and function.

Reports suggest as much as 75% of patients find Ketamine effective, with many experiencing relief after just one infusion.
Dr. Markintosh Barthelemy is a board-certified emergency medicine physician with extensive experience in emergency and urgent care, advocating for mental health as a critical component of overall well-being. He trained at the University of Buffalo, completing his residency in emergency medicine in 2009, and emphasizes the integration of mental wellness into healthcare.












